HW
Howard G. Welgus (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $302K of ARQT (10,000 sh × $30.21, as filed), executed Dec 1 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Oct 15
Filed Oct 19
Median ADV $51.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
ARQTRecent filings
ARQTSALE
Arcutis Biotherapeutics, Inc.
View filing →
$127K4,728 sh × $26.93
Exec Oct 15
Filed Oct 19 · 4:49 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $114K
4,730 sh × $24.18
Exec Sep 15
Filed Sep 17 · 4:06 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $124K
4,730 sh × $26.18
Exec Aug 17
Filed Aug 19 · 4:57 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $127K
4,730 sh × $26.91
Exec Jul 15
Filed Jul 17 · 4:01 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $164K
7,144 sh × $22.99
Exec May 1
Filed May 5 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $239K
10,000 sh × $23.88
Exec Apr 1
Filed Apr 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $256K
10,000 sh × $25.65
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $250K
10,000 sh × $25.05
Exec Feb 2
Filed Feb 4 · 5:30 PM ET More filings →